Reports
Sale
Global Immunodiagnostics Market Share, Size, Trends, Growth, Analysis: By Product: Reagents and Consumables, Instruments, Software and Services; By Technology: Chemiluminescence Immunoassay, Radioimmunoassay, Others; By Application; By End Use; Regional Analysis; Competitive Landscape; Industry Events and Developments; 2024-2032
Global Immunodiagnostics Market Outlook
The global immunodiagnostics market is expected to grow at a CAGR of 6.10% between 2024 and 2032. Key drivers of the market are increasing geriatric population, use of immunodiagnostics in rapid testing, and change in patient preferences.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Key Trends in the Market
Immunodiagnostics is a method of diagnosing conditions by reacting antibodies and antigen to detect unwanted antibodies and parasitic antigens. Immunodiagnostics finds applications in testing for cancer, bone diseases, infectious diseases, and autoimmune conditions, and can be used for people and animals.
- Infectious diseases, respiratory infections, HIV, and cancer, among others, have become widely prevalent. Early diagnostics can significantly improve patient outcomes, thereby increasing the demand for the immunodiagnostics and fuelling the market growth.
- Technological advancements are a key trend in the market, resulting in immunodiagnostics processes that are effective, easy to conduct, and cost-efficient. Developments are made in assays, diagnosis kits, and analysers are further increasing the opportunities for immunodiagnostics.
- Governments from all over the world are taking initiatives to inform people about the severity of diseases and the importance of early diagnosis to control the spread of diseases which is helping the growth of the immunodiagnostics market.
- Beyond clinical uses, additional applications of immunodiagnostics in areas such as forensic science, food analysis, and environmental analysis are expected to be an emerging trend in the market, that would help in examining parasite and pathogen presence.
Market Analysis
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Based on product, the market can be divided into reagents and consumables, instruments, and software and services. On the basis of technology, the market is segmented into chemiluminescence immunoassay, radioimmunoassay, enzyme-linked immunosorbent assay, fluorescent immunoassay, and rapid test, among others.
By application, the market is categorised into infectious diseases, drug monitoring, oncology and endocrinology, bone and mineral diseases, cardiac biomarkers, and autoimmune diseases, among others. Based on end use, the market is divided into hospitals, clinical laboratories, academic and research centres, and pharmaceutical and biotechnology industry, among others. By region, the market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa.
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis. The report gives a detailed analysis of the following key players in the global immunodiagnostics market covering their competitive landscape and latest developments like mergers, acquisitions, investments, and expansion plans.
- Abbott Laboratories
- ARKRAY, Inc.
- DiaSorin S.p.A.
- Johnson & Johnson Services, Inc.
- Biotest AG
- Others
Market Share by Product
Reagents and consumables are expected to account for a leading share in the immunodiagnostics market, as they play a critical role in the chemical reactions involved in immunodiagnostics. Due to the high demand for screening using immunoassay tests, new reagents are developed and manufactured.
Consumables are typically single-use products, and they also have a high rate of replacement, resulting in substantially high demand. Moreover, increasing number of immunodiagnostic tests along with increasing use of reagents in chemiluminescence and fluorescence has also contributed to the market growth.
Market Share by Region
Asia Pacific is expected to lead the demand for immunodiagnostics because of the high rate of prevalence of infectious diseases in this region. To contain and combat spread of infectious diseases, a number of new products are launched and approved after rigorous research and testing, contributing to the growth of the immunodiagnostics market. Other factors such as increase in geriatric population, rising investments in healthcare, and growing awareness among patients are expected to contribute to the market growth.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Competitive Landscape
Abbott Laboratories is an American healthcare and medical device company that was established in 1888 with headquarters in Illinois, United States. It develops products that help people keep track of their health and manage their lifestyle.
ARKRAY Inc. founded in 1960 is based out of Kyoto, Japan. It is a medical equipment company which manufactures clinical products for urinalysis, diabetes, and similar conditions. They manufacture products that are convenient, easy to use, and simple.
DiaSorin S.p.A. was founded in 2000 and has its headquarter in Saluggia, Italy. It is an Italian biotechnology company dealing with the manufacture and supply of in vitro diagnostic reagent kits, mainly used for molecular diagnostics and immunodiagnostics.
Other market players include Johnson & Johnson Services, Inc., and Biotest AG, among others.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product |
|
| Breakup by Technology |
|
| Breakup by Application |
|
| Breakup by End Use |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Market Snapshot
6.1 Global
6.2 Regional
7 Industry Opportunities and Challenges
8 Global Immunodiagnostics Market Analysis
8.1 Key Industry Highlights
8.2 Global Immunodiagnostics Historical Market (2018-2023)
8.3 Global Immunodiagnostics Market Forecast (2024-2032)
8.4 Global Immunodiagnostics Market by Product
8.4.1 Reagents and Consumables
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2018-2023)
8.4.1.3 Forecast Trend (2024-2032)
8.4.2 Instruments
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2018-2023)
8.4.2.3 Forecast Trend (2024-2032)
8.4.3 Software and Services
8.4.3.1 Market Share
8.4.3.2 Historical Trend (2018-2023)
8.4.3.3 Forecast Trend (2024-2032)
8.5 Global Immunodiagnostics Market by Technology
8.5.1 Chemiluminescence Immunoassay
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2018-2023)
8.5.1.3 Forecast Trend (2024-2032)
8.5.2 Radioimmunoassay
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2018-2023)
8.5.2.3 Forecast Trend (2024-2032)
8.5.3 Enzyme-Linked Immunosorbent Assay
8.5.3.1 Market Share
8.5.3.2 Historical Trend (2018-2023)
8.5.3.3 Forecast Trend (2024-2032)
8.5.4 Fluorescent Immunoassay
8.5.4.1 Market Share
8.5.4.2 Historical Trend (2018-2023)
8.5.4.3 Forecast Trend (2024-2032)
8.5.5 Rapid Test
8.5.5.1 Market Share
8.5.5.2 Historical Trend (2018-2023)
8.5.5.3 Forecast Trend (2024-2032)
8.5.6 Others
8.6 Global Immunodiagnostics Market by Application
8.6.1 Infectious Diseases
8.6.1.1 Market Share
8.6.1.2 Historical Trend (2018-2023)
8.6.1.3 Forecast Trend (2024-2032)
8.6.2 Drug Monitoring
8.6.2.1 Market Share
8.6.2.2 Historical Trend (2018-2023)
8.6.2.3 Forecast Trend (2024-2032)
8.6.3 Oncology and Endocrinology
8.6.3.1 Market Share
8.6.3.2 Historical Trend (2018-2023)
8.6.3.3 Forecast Trend (2024-2032)
8.6.4 Bone and Mineral Diseases
8.6.4.1 Market Share
8.6.4.2 Historical Trend (2018-2023)
8.6.4.3 Forecast Trend (2024-2032)
8.6.5 Cardiac Biomarkers
8.6.5.1 Market Share
8.6.5.2 Historical Trend (2018-2023)
8.6.5.3 Forecast Trend (2024-2032)
8.6.6 Autoimmune Diseases
8.6.6.1 Market Share
8.6.6.2 Historical Trend (2018-2023)
8.6.6.3 Forecast Trend (2024-2032)
8.6.7 Others
8.7 Global Immunodiagnostics Market by End Use
8.7.1 Hospitals
8.7.1.1 Market Share
8.7.1.2 Historical Trend (2018-2023)
8.7.1.3 Forecast Trend (2024-2032)
8.7.2 Clinical laboratories
8.7.2.1 Market Share
8.7.2.2 Historical Trend (2018-2023)
8.7.2.3 Forecast Trend (2024-2032)
8.7.3 Academic and Research Centres
8.7.3.1 Market Share
8.7.3.2 Historical Trend (2018-2023)
8.7.3.3 Forecast Trend (2024-2032)
8.7.4 Pharmaceutical and Biotechnology Industry
8.7.4.1 Market Share
8.7.4.2 Historical Trend (2018-2023)
8.7.4.3 Forecast Trend (2024-2032)
8.7.5 Others
8.8 Global Immunodiagnostics Market by Region
8.8.1 Market Share
8.8.1.1 North America
8.8.1.2 Europe
8.8.1.3 Asia Pacific
8.8.1.4 Latin America
8.8.1.5 Middle East and Africa
9 Regional Analysis
9.1 North America
9.1.1 Historical Trend (2018-2023)
9.1.2 Forecast Trend (2024-2032)
9.1.3 Breakup by Country
9.1.3.1 United States of America
9.1.3.2 Canada
9.2 Europe
9.2.1 Historical Trend (2018-2023)
9.2.2 Forecast Trend (2024-2032)
9.2.3 Breakup by Country
9.2.3.1 United Kingdom
9.2.3.2 Germany
9.2.3.3 France
9.2.3.4 Italy
9.2.3.5 Others
9.3 Asia Pacific
9.3.1 Historical Trend (2018-2023)
9.3.2 Forecast Trend (2024-2032)
9.3.3 Breakup by Country
9.3.3.1 China
9.3.3.2 Japan
9.3.3.3 India
9.3.3.4 ASEAN
9.3.3.5 Australia
9.3.3.6 Others
9.4 Latin America
9.4.1 Historical Trend (2018-2023)
9.4.2 Forecast Trend (2024-2032)
9.4.3 Breakup by Country
9.4.3.1 Brazil
9.4.3.2 Argentina
9.4.3.3 Mexico
9.4.3.4 Others
9.5 Middle East and Africa
9.5.1 Historical Trend (2018-2023)
9.5.2 Forecast Trend (2024-2032)
9.5.3 Breakup by Country
9.5.3.1 Saudi Arabia
9.5.3.2 United Arab Emirates
9.5.3.3 Nigeria
9.5.3.4 South Africa
9.5.3.5 Others
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
11 Competitive Landscape
11.1 Market Structure
11.2 Company Profiles
11.2.1 Abbott Laboratories
11.2.1.1 Company Overview
11.2.1.2 Product Portfolio
11.2.1.3 Demographic Reach and Achievements
11.2.1.4 Certifications
11.2.2 ARKRAY, Inc.
11.2.2.1 Company Overview
11.2.2.2 Product Portfolio
11.2.2.3 Demographic Reach and Achievements
11.2.2.4 Certifications
11.2.3 DiaSorin S.p.A.
11.2.3.1 Company Overview
11.2.3.2 Product Portfolio
11.2.3.3 Demographic Reach and Achievements
11.2.3.4 Certifications
11.2.4 Johnson & Johnson Services, Inc.
11.2.4.1 Company Overview
11.2.4.2 Product Portfolio
11.2.4.3 Demographic Reach and Achievements
11.2.4.4 Certifications
11.2.5 Biotest AG
11.2.5.1 Company Overview
11.2.5.2 Product Portfolio
11.2.5.3 Demographic Reach and Achievements
11.2.5.4 Certifications
11.2.6 Others
12 Industry Events and Developments
List of Key Figures and Tables
1. Global Immunodiagnostics Market: Key Industry Highlights, 2017 and 2021
2. Global Immunodiagnostics Historical Market: Breakup by Product (USD Million), 2018-2023
3. Global Immunodiagnostics Market Forecast: Breakup by Product (USD Million), 2024-2032
4. Global Immunodiagnostics Historical Market: Breakup by Technology (USD Million), 2018-2023
5. Global Immunodiagnostics Market Forecast: Breakup by Technology (USD Million), 2024-2032
6. Global Immunodiagnostics Historical Market: Breakup by Application (USD Million), 2018-2023
7. Global Immunodiagnostics Market Forecast: Breakup by Application (USD Million), 2024-2032
8. Global Immunodiagnostics Historical Market: Breakup by End Use (USD Million), 2018-2023
9. Global Immunodiagnostics Market Forecast: Breakup by End Use (USD Million), 2024-2032
10. Global Immunodiagnostics Historical Market: Breakup by Region (USD Million), 2018-2023
11. Global Immunodiagnostics Market Forecast: Breakup by Region (USD Million), 2024-2032
12. North America Immunodiagnostics Historical Market: Breakup by Country (USD Million), 2018-2023
13. North America Immunodiagnostics Market Forecast: Breakup by Country (USD Million), 2024-2032
14. Europe Immunodiagnostics Historical Market: Breakup by Country (USD Million), 2018-2023
15. Europe Immunodiagnostics Market Forecast: Breakup by Country (USD Million), 2024-2032
16. Asia Pacific Immunodiagnostics Historical Market: Breakup by Country (USD Million), 2018-2023
17. Asia Pacific Immunodiagnostics Market Forecast: Breakup by Country (USD Million), 2024-2032
18. Latin America Immunodiagnostics Historical Market: Breakup by Country (USD Million), 2018-2023
19. Latin America Immunodiagnostics Market Forecast: Breakup by Country (USD Million), 2024-2032
20. Middle East and Africa Immunodiagnostics Historical Market: Breakup by Country (USD Million), 2018-2023
21. Middle East and Africa Immunodiagnostics Market Forecast: Breakup by Country (USD Million), 2024-2032
22. Global Immunodiagnostics Market Structure
Key Questions Answered in the Report
The global market for immunodiagnostics is expected to grow at a CAGR of 6.10% between 2024 and 2032.
Key drivers of the market are increasing geriatric population, use of immunodiagnostic in rapid testing, and change in patient preferences.
The key trends of the market are growing prevalence of infectious diseases, technological advancements, and increasing awareness regarding early diagnosis of conditions.
Key market players include Abbott Laboratories, ARKRAY, Inc., DiaSorin S.p.A., Johnson & Johnson Services, Inc., and Biotest AG, among others.
Immunodiagnostics is a method of diagnosing conditions by reacting antibodies and antigen to detect unwanted antibodies and parasitic antigens.
The global immunodiagnostics market is segmented based on product, technology, application, end use, and region.
Primary applications of immunodiagnostics are infectious diseases, drug monitoring, oncology and endocrinology, bone and mineral diseases, cardiac biomarkers, and autoimmune diseases, among others.
The various technologies for immunodiagnostics include chemiluminescence immunoassay, radioimmunoassay, enzyme-linked immunosorbent assay, fluorescent immunoassay, and rapid test, among others.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER